The collapse of AmTrust's relationship with the sole distributor for its $500mn Italian medical malpractice business could see its dominant market position eroded, sources suggest.
The collapse of AmTrust's relationship with the sole distributor for its $500mn Italian medical malpractice business could see its dominant market position eroded, sources suggest.